Uterine Cancer Global Clinical Trials Review, H2, 2011

GlobalData, November 2011, Pages: 101

Uterine Cancer Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, “Uterine Cancer Global Clinical Trials Review, H2, 2011" provides data on the Uterine Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uterine Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Uterine Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Uterine Cancer Clinical Trials, Trial Designs, Trial Designs, Subjects Recruited, Unaccomplished Trials of Uterine Cancer, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Uterine Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Uterine Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Uterine Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Sanofi
Clinical Trial Overview of Sanofi
Tigris Pharmaceuticals, Inc.
Clinical Trial Overview of Tigris Pharmaceuticals, Inc.
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
GAAD Medical Research Institute Inc
Clinical Trial Overview of GAAD Medical Research Institute Inc
Brabant Research, Inc.
Clinical Trial Overview of Brabant Research, Inc.
Eurofarma
Clinical Trial Overview of Eurofarma
Plethora Solutions Limited
Clinical Trial Overview of Plethora Solutions Limited
STI Pharmaceuticals Limited
Clinical Trial Overview of STI Pharmaceuticals Limited
Altor BioScience Corporation
Clinical Trial Overview of Altor BioScience Corporation
Zeria Pharmaceutical Co Ltd
Clinical Trial Overview of Zeria Pharmaceutical Co Ltd
InSightec Ltd.
Clinical Trial Overview of InSightec Ltd.
Precision Therapeutics, Inc.
Clinical Trial Overview of Precision Therapeutics, Inc.
Grifols, S.A.
Clinical Trial Overview of Grifols, S.A.
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Angiotech Pharmaceuticals, Inc.
Clinical Trial Overview of Angiotech Pharmaceuticals, Inc.
CytoCore, Inc.
Clinical Trial Overview of CytoCore, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Gynecologic Oncology Group
Clinical Trial Overview of Gynecologic Oncology Group
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Montefiore Medical Center
Clinical Trial Overview of Montefiore Medical Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
University of New Mexico
Clinical Trial Overview of University of New Mexico
USC Norris Comprehensive Cancer Center
Clinical Trial Overview of USC Norris Comprehensive Cancer Center
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
University of Alabama at Birmingham
Clinical Trial Overview of University of Alabama at Birmingham
University Health Network
Clinical Trial Overview of University Health Network
Albert Einstein College of Medicine of Yeshiva University
Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University
University Hospital, Tours
Clinical Trial Overview of University Hospital, Tours
Wake Forest University
Clinical Trial Overview of Wake Forest University
Taipei Veterans General Hospital
Clinical Trial Overview of Taipei Veterans General Hospital
Centre Oscar Lambret
Clinical Trial Overview of Centre Oscar Lambret
University of Maryland Greenebaum Cancer Center
Clinical Trial Overview of University of Maryland Greenebaum Cancer Center
National Taiwan University Hospital
Clinical Trial Overview of National Taiwan University Hospital
Barbara Ann Karmanos Cancer Institute
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
University of Michigan Comprehensive Cancer Center
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Five Key Clinical Profiles
Appendix
Abbreviations
NCI: National Cancer Institute
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Uterine Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Uterine Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Uterine Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Uterine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011-
Uterine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2011-
Uterine Cancer Therapeutics Clinical Trials, North America, Top Countries, 2011-
Uterine Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011-
Uterine Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011-
Uterine Cancer Therapeutics Clinical Trials, BRIC Countries, 2011-
Uterine Cancer Therapeutics Clinical Trials, G7 Countries, 2011-
Uterine Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Uterine Cancer Therapeutics Clinical Trials, E7 Countries, 2011-
Uterine Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Uterine Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Uterine Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011-
Uterine Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Uterine Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2011-
Uterine Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2011-
Uterine Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2011-
Uterine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Uterine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Uterine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Uterine Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Tigris Pharmaceuticals, Inc., 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GAAD Medical Research Institute Inc, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Brabant Research, Inc., 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eurofarma, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Plethora Solutions Limited, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by STI Pharmaceuticals Limited, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Altor BioScience Corporation, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by InSightec Ltd., 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Precision Therapeutics, Inc., 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Angiotech Pharmaceuticals, Inc., 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by CytoCore, Inc., 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Montefiore Medical Center, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of New Mexico, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by USC Norris Comprehensive Cancer Center, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Tours, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taipei Veterans General Hospital, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Oscar Lambret, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland Greenebaum Cancer Center, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2011-
Uterine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2011-

List of Figures
Uterine Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Uterine Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Uterine Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Uterine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011-
Uterine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011-
Uterine Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2011-
Uterine Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011-
Uterine Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011-
Uterine Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2011-
Uterine Cancer Therapeutics Clinical Trials, G7 Countries (%), 2011-
Uterine Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Uterine Cancer Therapeutics Clinical Trials, E7 Countries (%), 2011-
Uterine Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Uterine Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Uterine Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011-
Uterine Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Uterine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Uterine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Uterine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Uterine Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
GlobalData Methodology

Customers who bought this item also bought

• Myelofibrosis Global Clinical Trials Review, H2, 2012
• Other Metabolic Disorders Global Clinical Trials Review, H1, 2012
• Cancer Cachexia Global Clinical Trials Review, H1, 2013
• Osteoporosis Global Clinical Trials Review, H2, 2012
• Shock Global Clinical Trials Review, H2, 2012
• Atopic Dermatitis (Eczema) Global Clinical Trials Review, H1, 2012
• Asthma Global Clinical Trials Review, H1, 2012
• Sleep Apnea Global Clinical Trials Review, H1, 2012
• Bronchitis Global Clinical Trials Review, H2, 2012
• Open-Angle Glaucoma Global Clinical Trials Review, H1, 2012